Trospium

Chemical formula: C₂₅H₃₀NO₃+  Molecular mass: 392.518 g/mol  PubChem compound: 5284632

Therapeutic indications

Trospium is indicated for:

Overactive bladder

Population group: only adults (18 years old or older)

Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder (e.g. idiopathic or neurologic detrusor overactivity).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Trospium is contraindicated in the following cases:

Urinary retention, toxic megacolon, myasthenia gravis, narrow-angle glaucoma, tachyarrhythmia

at least one of
Retention of urine
† Toxic megacolon
Myasthenia gravis
Angle-closure glaucoma
Tachyarrhythmia

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2020: REGURIN XL Prolonged-release capsule, hard
Summary of Product Characteristics (SPC) 2018: TROSPIUM CHLORIDE Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈